Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane and Postoperative Cognitive Function After Laparoscopic Partial Hepatectomy
ChiCTR2200066393Phase 4Not yet recruiting
- Sponsor
- Liuzhou People's Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sevoflurane in post-operative cognitive decline (POCD) (2 arms), sponsored by Liuzhou People's Hospital. Primary endpoints: MMSE score at 7 days postoperatively, Telephone Interview for Cognitive Status-Modified (TICS-M) score at 30 days postoperatively and 5 more. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
sevoflurane
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2200066393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066393.